Preanalytical handling of samples for measurement of plasma lactate in HIV patients

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 63, Issue 6, 2003, Pages 449-454

  Andersen, O ^a,b   Haugaard, S B ^a   Jorgensen L T ^a   Sorensen S ^a   Nielsen, J O ^a   Madsbad, S ^a   Iversen, J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Anion gap; Lactate; Lactic acidosis; NRTI; pH; Preanalytical variation

Indexed keywords

ANTIRETROVIRUS AGENT; HEPARIN; ICE; LACTIC ACID;

ADULT; ANION GAP; ARTICLE; BLOOD PH; BLOOD SAMPLING; CONTROLLED STUDY; ERROR; GLUCOSE BLOOD LEVEL; GLYCOLYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LACTATE BLOOD LEVEL; MALE; MEASUREMENT; PRIORITY JOURNAL; ROOM TEMPERATURE; STORAGE TEMPERATURE; TUBE; VENOUS STASIS;

ACIDOSIS, LACTIC; ADULT; BLOOD PRESERVATION; GLYCOLYSIS; HIV INFECTIONS; HUMANS; HYDROGEN-ION CONCENTRATION; LACTIC ACID; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TEMPERATURE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0142030136     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510310005128     Document Type: Article

References (14)

1. Arnaudo E, Dalakas M, Shanske S, Moraes CT, Dimauro S, Schon EA. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 1991; 337: 508-10.
2. Casademont J, Barrientos A, Grau JM, Pedrol E, Estivill X, Urbano-Marquez A, Nunes V. The effect of zidovudine on skeletal muscle mtDNA in HIV-1-infected patients with mild or no muscle dysfunction. Brain 1996; 119: 1357-64.
3. Brinkman K, ter Hofstede HJ, Burger DM, Smeitink JA, Koopmans PP. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS 1998; 12: 1735-44.
4. Moyle GJ, Datta D, Mandalia S, Morlese J, Asboe D, Gazzard BG. Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors. AIDS 2002; 16: 1341-9.
5. John M, Moore CB, James IR, Nolan D, Upton RP, McKinnon EJ, Mallal SA. Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy. AIDS 2001; 15: 717-23.
6. Fortgang IS, Belitsos PC, Chaisson RE, Moore RD. Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy. Am J Gastroenterol 1995; 90: 1433-6.
7. Moyle G. Hyperlactatemia and lactic acidosis during antiretroviral therapy: causes, management and possible aetiologies. AIDS Rev 2001; 3: 150-6.
8. de Keijzer MH, Brandts RW, Brans PG. Evaluation of a biosensor for the measurement of lactate in whole blood. Clin Biochem 1999; 32: 109-12.
9. Chan AY, Swaminathan R, Cockram CS. Effectiveness of sodium fluoride as a preservative of glucose in blood. Clin Chem 1989; 35: 315-7.
10. Wandrup J, Tvede K, Grinsted J, Jordening H. "Stat" measurements of L-lactate in whole blood and cerebrospinal fluid assessed. Clin Chem 1989; 35: 1740-3.
11. Martin L. All you really need to know to interpret arterial blood gases. Philadelphia: Lippincott Williams & Wilkins; 1999.
12. Luft D, Deichsel G, Schmulling RM, Stein W, Eggstein M. Definition of clinically relevant lactic acidosis in patients with internal diseases. Am J Clin Pathol 1983; 80: 484-9.
13. Brinkman K. Evidence for mitochondrial toxicity: lactic acidosis as proof of concept. J HIV Ther 2001; 6: 13-6.
14. Bernstein JM, Aduen J, Bhatiani A. Simultaneous arterial and venous lactate determination in critically ill patients. Crit Care Med 1994; 22: Abstr 227.